ATE125571T1 - Interleukin-1-inhibitor. - Google Patents
Interleukin-1-inhibitor.Info
- Publication number
- ATE125571T1 ATE125571T1 AT90401343T AT90401343T ATE125571T1 AT E125571 T1 ATE125571 T1 AT E125571T1 AT 90401343 T AT90401343 T AT 90401343T AT 90401343 T AT90401343 T AT 90401343T AT E125571 T1 ATE125571 T1 AT E125571T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- interleukin
- inhibitor
- directed
- immunosuppression
- Prior art date
Links
- 102000000589 Interleukin-1 Human genes 0.000 title abstract 2
- 108010002352 Interleukin-1 Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 206010062016 Immunosuppression Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35433089A | 1989-05-19 | 1989-05-19 | |
| US50899990A | 1990-04-12 | 1990-04-12 | |
| US52527490A | 1990-05-17 | 1990-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE125571T1 true ATE125571T1 (de) | 1995-08-15 |
Family
ID=27408176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90401343T ATE125571T1 (de) | 1989-05-19 | 1990-05-21 | Interleukin-1-inhibitor. |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0398817B1 (de) |
| JP (1) | JP2863265B2 (de) |
| AT (1) | ATE125571T1 (de) |
| CA (1) | CA2017315C (de) |
| DE (1) | DE69021128T2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
| US6159460A (en) * | 1988-05-27 | 2000-12-12 | Amgen Inc. | Method for treating interleukin-1 mediated diseases |
| US6858409B1 (en) | 1988-05-27 | 2005-02-22 | Amgen Inc. | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors |
| AU649245B2 (en) * | 1990-04-02 | 1994-05-19 | Amgen, Inc. | Methods for treating interleukin-1 mediated diseases |
| DE4106570A1 (de) * | 1991-03-01 | 1992-09-03 | Max Planck Gesellschaft | Neue inhibitoren der endothelzell-proliferation |
| AU6137396A (en) * | 1995-09-13 | 1997-04-01 | Takeda Chemical Industries Ltd. | Immunosuppressant |
| US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
| EP1416957A4 (de) * | 2001-07-25 | 2006-08-02 | Nuvelo Inc | Behandlung von immunerkrankungen und b-zellen-erkrankungen |
-
1990
- 1990-05-19 JP JP2130125A patent/JP2863265B2/ja not_active Expired - Fee Related
- 1990-05-21 AT AT90401343T patent/ATE125571T1/de not_active IP Right Cessation
- 1990-05-21 EP EP90401343A patent/EP0398817B1/de not_active Expired - Lifetime
- 1990-05-21 DE DE69021128T patent/DE69021128T2/de not_active Expired - Fee Related
- 1990-05-22 CA CA002017315A patent/CA2017315C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2863265B2 (ja) | 1999-03-03 |
| JPH03128397A (ja) | 1991-05-31 |
| EP0398817B1 (de) | 1995-07-26 |
| DE69021128D1 (de) | 1995-08-31 |
| CA2017315C (en) | 2000-07-18 |
| CA2017315A1 (en) | 1990-11-19 |
| DE69021128T2 (de) | 1996-02-29 |
| EP0398817A1 (de) | 1990-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2071484T3 (es) | Derivados de 2,4-diaminoquinazolinas para aumentar la actividad antitumoral. | |
| CY1107495T1 (el) | Χρηση παραγωγων τετρακυκλινης για να αυξανεται παραγωγη ιντepλευκινης-10 | |
| ES8705845A1 (es) | Procedimiento de preparar derivados benzonaftalenicos de utilidad terapeutica y cosmetica | |
| NZ335981A (en) | Ketobenzamides as calpain inhibitors | |
| EP0831836A4 (de) | Synthetische katalytisch freie-radikalfänger zur verwendung als antioxydantien zur vorbeugung und heilung von krankheiten | |
| BG91270A (bg) | Антивирусно и антибактериално средство и метод за използването му | |
| BR9910251A (pt) | Estimulação hematopoiética | |
| FI950255A0 (fi) | Venyvä absorboiva rakenne | |
| PT804252E (pt) | Agentes queladores metalicos que contem monoaminas diamidas e tiois | |
| EP0559632A3 (de) | ||
| IT8848329A0 (it) | Trattamento batterico di conservazione della qualita' del fieno tramite aggiunta di microorganismi del genere bacillus | |
| ATE206708T1 (de) | Benzimidazolonderivate mit zentraler dopaminerger aktivität | |
| DE69021128D1 (de) | Interleukin-1-Inhibitor. | |
| PT775118E (pt) | Derivados de benzimidazole com actividade dopaminergica | |
| NO913129L (no) | Nytt trombolytisk middel. | |
| ES2068714T3 (es) | Derivados de pirimidina para aumentar la actividad antitumoral. | |
| ES2149952T3 (es) | L-arginina y analogos como inhibidores de la agregacion de trombocitos. | |
| EP0373540A3 (de) | Verfahren zur Reinigung des Fibroblast-Wachstumsfaktor-Proteins | |
| IT8748663A0 (it) | N-alchilammidi della dl e l(-)carni tina dotate di attivita'antibatteri ca,procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che le contengono | |
| ES2066096T3 (es) | 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos. | |
| ATE117549T1 (de) | Lysyl-oxidase-inhibitoren. | |
| ATE128964T1 (de) | Anwendung von beta-alethin in zellkultur und therapie. | |
| CA2099497A1 (en) | Peptides with anticoagulant activity | |
| PH23658A (en) | Improved method of treating tumors with autologous lymphokine activated killer,interleukin-2 and an ornithine decarboxylase inhibitor | |
| RU94024337A (ru) | Антиметастатическое средство |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |